vs
Side-by-side financial comparison of ADC Therapeutics SA (ADCT) and Laird Superfood, Inc. (LSF). Click either name above to swap in a different company.
ADC Therapeutics SA is the larger business by last-quarter revenue ($23.1M vs $13.3M, roughly 1.7× Laird Superfood, Inc.). On growth, ADC Therapeutics SA posted the faster year-over-year revenue change (36.4% vs 15.0%). Over the past eight quarters, Laird Superfood, Inc.'s revenue compounded faster (16.1% CAGR vs 13.7%).
ADC Telecommunications, Inc. was a communications company in Eden Prairie, Minnesota, a southwest suburb of Minneapolis. It was acquired by TE Connectivity in December 2010 and ceased to exist as a separate entity. ADC products were sold by CommScope after it acquired the Broadband Network Solutions business unit from TE Connectivity in August 2015.
Laird Superfood, Inc. develops, manufactures and sells a portfolio of plant-based functional superfood products, including premium coffee creamers, hydration blends, nutritional supplements, and plant-powered snacks. It serves health-conscious consumers through direct-to-consumer e-commerce platforms and offline retail partners, mainly operating in the North American market with a focus on sustainably sourced clean ingredients.
ADCT vs LSF — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $23.1M | $13.3M |
| Net Profit | — | $-1.8M |
| Gross Margin | — | 34.1% |
| Operating Margin | -77.7% | -13.5% |
| Net Margin | — | -13.2% |
| Revenue YoY | 36.4% | 15.0% |
| Net Profit YoY | — | -341.4% |
| EPS (diluted) | $0.04 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $23.1M | $13.3M | ||
| Q3 25 | $15.8M | $12.9M | ||
| Q2 25 | $18.1M | $12.0M | ||
| Q1 25 | $17.4M | $11.7M | ||
| Q4 24 | $16.9M | $11.6M | ||
| Q3 24 | $18.0M | $11.8M | ||
| Q2 24 | $17.0M | $10.0M | ||
| Q1 24 | $17.8M | $9.9M |
| Q4 25 | — | $-1.8M | ||
| Q3 25 | $-41.0M | $-975.1K | ||
| Q2 25 | $-56.6M | $-362.2K | ||
| Q1 25 | $-38.6M | $-156.2K | ||
| Q4 24 | — | $-398.4K | ||
| Q3 24 | $-44.0M | $-166.1K | ||
| Q2 24 | $-36.5M | $-239.1K | ||
| Q1 24 | $-46.6M | $-1.0M |
| Q4 25 | — | 34.1% | ||
| Q3 25 | — | 36.5% | ||
| Q2 25 | — | 39.9% | ||
| Q1 25 | — | 41.9% | ||
| Q4 24 | — | 38.6% | ||
| Q3 24 | — | 43.0% | ||
| Q2 24 | — | 41.8% | ||
| Q1 24 | — | 40.0% |
| Q4 25 | -77.7% | -13.5% | ||
| Q3 25 | -196.6% | -7.7% | ||
| Q2 25 | -244.1% | -3.3% | ||
| Q1 25 | -163.5% | -1.9% | ||
| Q4 24 | -191.8% | -4.1% | ||
| Q3 24 | -197.4% | -2.3% | ||
| Q2 24 | -170.5% | -3.4% | ||
| Q1 24 | -188.3% | -11.0% |
| Q4 25 | — | -13.2% | ||
| Q3 25 | -260.1% | -7.6% | ||
| Q2 25 | -313.2% | -3.0% | ||
| Q1 25 | -221.8% | -1.3% | ||
| Q4 24 | — | -3.4% | ||
| Q3 24 | -244.1% | -1.4% | ||
| Q2 24 | -214.6% | -2.4% | ||
| Q1 24 | -261.1% | -10.3% |
| Q4 25 | $0.04 | — | ||
| Q3 25 | $-0.30 | — | ||
| Q2 25 | $-0.50 | — | ||
| Q1 25 | $-0.36 | — | ||
| Q4 24 | $-0.26 | — | ||
| Q3 24 | $-0.42 | — | ||
| Q2 24 | $-0.38 | — | ||
| Q1 24 | $-0.56 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $261.3M | $5.1M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $-185.8M | $11.5M |
| Total Assets | $323.1M | $19.2M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $261.3M | $5.1M | ||
| Q3 25 | $234.7M | $5.1M | ||
| Q2 25 | $264.6M | $3.9M | ||
| Q1 25 | $194.7M | $7.0M | ||
| Q4 24 | $250.9M | $8.3M | ||
| Q3 24 | $274.3M | $7.9M | ||
| Q2 24 | $300.1M | $7.6M | ||
| Q1 24 | $234.3M | $7.1M |
| Q4 25 | $-185.8M | $11.5M | ||
| Q3 25 | $-238.2M | $12.8M | ||
| Q2 25 | $-199.2M | $13.4M | ||
| Q1 25 | $-238.2M | $13.3M | ||
| Q4 24 | $-202.6M | $13.2M | ||
| Q3 24 | $-171.9M | $13.1M | ||
| Q2 24 | $-131.7M | $12.6M | ||
| Q1 24 | $-194.4M | $12.7M |
| Q4 25 | $323.1M | $19.2M | ||
| Q3 25 | $289.8M | $18.9M | ||
| Q2 25 | $321.6M | $20.4M | ||
| Q1 25 | $272.5M | $21.5M | ||
| Q4 24 | $322.0M | $19.3M | ||
| Q3 24 | $349.1M | $18.8M | ||
| Q2 24 | $371.8M | $18.0M | ||
| Q1 24 | $308.0M | $17.6M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-31.1M | $68.4K |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | 0.0% | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-31.1M | $68.4K | ||
| Q3 25 | $-29.6M | $1.2M | ||
| Q2 25 | $-24.1M | $-2.8M | ||
| Q1 25 | $-56.3M | $-1.3M | ||
| Q4 24 | $-21.9M | $339.2K | ||
| Q3 24 | $-25.0M | $305.8K | ||
| Q2 24 | $-32.8M | $642.7K | ||
| Q1 24 | $-44.1M | $-422.3K |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | $-56.6M | — | ||
| Q4 24 | $-21.9M | — | ||
| Q3 24 | $-25.3M | — | ||
| Q2 24 | $-32.9M | — | ||
| Q1 24 | $-44.6M | — |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | -325.2% | — | ||
| Q4 24 | -129.8% | — | ||
| Q3 24 | -140.2% | — | ||
| Q2 24 | -193.0% | — | ||
| Q1 24 | -250.0% | — |
| Q4 25 | 0.0% | — | ||
| Q3 25 | 0.0% | — | ||
| Q2 25 | 0.0% | — | ||
| Q1 25 | 1.5% | — | ||
| Q4 24 | 0.5% | — | ||
| Q3 24 | 1.2% | — | ||
| Q2 24 | 0.2% | — | ||
| Q1 24 | 3.0% | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ADCT
Segment breakdown not available.
LSF
| Wholesale | $7.0M | 52% |
| Coffee Tea And Hot Chocolate Products | $4.4M | 33% |
| Hydration And Beverage Enhancing Supplements | $1.6M | 12% |
| Other | $352.6K | 3% |
